SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: mc who wrote (6800)4/10/1998 12:54:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
Gary,

I agree with you 100%. You are missing my perspective. I am trying to say that from an institutional investor point of view and in terms of stock price, Vivus is hurting because of the perception that Viagra will steal MUSE's show and revenue growth. Once this perception dissipates things will look much better for Vivus. The only reason the short interest is not covering is because there is an agenda by some deep pockets to see this company and its product flushed down the toilet.

BigKNY3 should maybe point out who the real impalers are.